| Destination - Tackling diseases and reducing disease burden |
| HORIZON-HLTH-2025-01-DISEASE-01: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections |
RIA |
45.00 |
15.00 |
3 |
16 Sep 2025 |
| HORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential |
RIA |
50.00 |
10.00 |
5 |
16 Sep 2025 |
| HORIZON-HLTH-2025-01-DISEASE-04: Leveraging artificial intelligence for pandemic preparedness and response |
RIA |
35.00 |
6.00 to 8.00 |
5 |
16 Sep 2025 |
| HORIZON-HLTH-2025-01-DISEASE-05: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) |
CSA |
2.00 |
2.00 |
1 |
16 Sep 2025 |
| HORIZON-HLTH-2025-01-DISEASE-06: Implementation research addressing strategies to strengthen health systems for equitable high quality care and health outcomes in the context of non-communicable diseases (GACD) |
RIA |
20.00 |
3.00 to 4.00 |
5 |
16 Sep 2025 |
| HORIZON-HLTH-2025-01-DISEASE-07: Tackling high-burden for patients and under researched medical conditions |
RIA |
30.00 |
6.00 |
5 |
16 Sep 2025 |
| HORIZON-HLTH-2025-03-DISEASE-02-two-stage: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders |
RIA |
50.00 |
6.00 to 8.00 |
7 |
16 Sep 2025 (stage 1) |
| Destination - Ensuring equal access to innovative, sustainable, and high-quality healthcare |
| HORIZON-HLTH-2025-01-CARE-01: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU) |
RIA |
40.00 |
15.00 to 20.00 |
2 |
16 Sep 2025 |
| Developing and using new tools, technologies and digital solutions for a healthy society |
| HORIZON-HLTH-2025-01-TOOL-01: Enhancing cell therapies with genomic techniques |
RIA |
50.00 |
8.00 to 10.00 |
5 |
16 Sep 2025 |
| HORIZON-HLTH-2025-01-TOOL-02: Advancing cell secretome-based therapies |
RIA |
40.00 |
9.00 to 13.00 |
3 |
16 Sep 2025 |
| HORIZON-HLTH-2025-01-TOOL-03: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU) |
RIA |
50.00 |
15.00 to 17.00 |
3 |
16 Sep 2025 |
| HORIZON-HLTH-2025-01-TOOL-05: Boosting the translation of biotech research into innovative health therapies |
RIA |
80.00 |
4.00 to 8.00 |
10 |
16 Sep 2025 |
| Destination - Maintaining an innovative, sustainable, and competitive EU health industry |
| HORIZON-HLTH-2025-01-IND-01: Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs) |
IA |
40.00 |
6.00 to 8.00 |
5 |
16 Sep 2025 |
| HORIZON-HLTH-2025-01-IND-02: Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices |
CSA |
4.00 |
4.00 |
1 |
16 Sep 2025 |
| HORIZON-HLTH-2025-03-IND-03-two-stage: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices |
RIA |
40.00 |
6.00 to 8.00 |
5 |
16 Sep 2025 (stage 1) |
| Destination - Staying healthy in a rapidly changing society |
| HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage: Improving the quality of life of persons with intellectual disabilities and their families |
RIA |
40.00 |
6.00 to 8.00 |
5 |
16 Sep 2025 (stage 1) |
| Destination - Living and working in a health-promoting environment |
| HORIZON-HLTH-2025-03-ENVHLTH-01-two-stage: The impact of pollution on the development and progression of brain diseases and disorders |
RIA |
40.00 |
6.00 to 7.00 |
6 |
16 Sep 2025 (stage 1) |
| HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage: Advancing knowledge on the impacts of micro- and nanoplastics on human health |
RIA |
40.00 |
7.00 to 8.00 |
5 |
16 Sep 2025 (stage 1) |
